TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL. - Archive ouverte HAL Access content directly
Journal Articles Scientific Reports Year : 2015

TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL.

(1, 2) , (1, 3) , (4, 5, 6) , (7) , (1) , (8, 9) , (10) , (10, 11) , (1) , (1) , (1) , (2, 3) , (3) , (2, 3) , (12) , (9) , (10, 11) , (7) , (12) , (5, 6, 4) , (2, 3) , (2, 3) , (1)
1
2
3
4
5
6
7
8
9
10
11
12

Abstract

Translationally Controlled Tumor Protein (TCTP) is anti-apoptotic, key in development and cancer, however without the typical Bcl2 family members' structure. Here we report that TCTP contains a BH3-like domain and forms heterocomplexes with Bcl-xL. The crystal structure of a Bcl-xL deletion variant-TCTP11-31 complex reveals that TCTP refolds in a helical conformation upon binding the BH3-groove of Bcl-xL, although lacking the h1-subregion interaction. Experiments using in vitro-vivo reconstituted systems and TCTP(+/-) mice indicate that TCTP activates the anti-apoptotic function of Bcl-xL, in contrast to all other BH3-proteins. Replacing the non-conserved h1 of TCTP by that of Bax drastically increases the affinity of this hybrid for Bcl-xL, modifying its biological properties. This work reveals a novel class of BH3-proteins potentiating the anti-apoptotic function of Bcl-xL.
Fichier principal
Vignette du fichier
2016-thebaut-TCTP.pdf (1.42 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-01334033 , version 1 (20-06-2016)

Identifiers

Cite

Stéphanie Thébault, Morgane Agez, Xiaoke Chi, Johann Stojko, Vincent Cura, et al.. TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL.. Scientific Reports, 2015, 6 (1), pp.19725. ⟨10.1038/srep19725⟩. ⟨inserm-01334033⟩
386 View
222 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More